Leads for antitubercular compounds from kinase inhibitor library screens-Reference-Cited by-同舟云学术

Leads for antitubercular compounds from kinase inhibitor library screens

Published:2010-11 Issue:6 Volume:90 Page:354-360
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Magnet Sophie,Hartkoorn Ruben C.,Székely Rita,Pató János,Triccas James A.,Schneider Patricia,Szántai-Kis Csaba,Őrfi László,Chambon Marc,Banfi Damiano,Bueno Manuel,Turcatti Gerardo,Kéri György,Cole Stewart T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference34 articles.

1. Multidrug-resistant and extensively drug-resistant tuberculosis: a review;Chan;Curr Opin Infect Dis,2008

2. Rising standards for tuberculosis drug development;Balganesh;Trends Pharmacol Sci,2008

3. Drugs for bad bugs: confronting the challenges of antibacterial discovery;Payne;Nat Rev Drug Discov,2007

4. OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice;Matsumoto;PLoS Med,2006

5. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis;Andries;Science,2005

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DprE1 and Ddn as promising therapeutic targets in the development of novel anti-tuberculosis nitroaromatic drugs;European Journal of Medicinal Chemistry;2024-08

2. Modulators targeting protein-protein interactions in Mycobacterium tuberculosis;Microbiological Research;2024-07

3. Recent advances in the development of DprE1 inhibitors using AI/CADD approaches;Drug Discovery Today;2024-06

4. Discovery and development of new antibacterial drugs;Microbial Genomics: Clinical, Pharmaceutical, and Industrial Applications;2024

5. Structure-activity relationship mediated molecular insights of DprE1 inhibitors: A Comprehensive Review;Journal of Biomolecular Structure and Dynamics;2023-07-03